Clinical Trial Update: A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing standard of care vs treat-to-target with telemonitoring and patient education in patients with ulcerative colitis initiating …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Ulcerative Colitis | Phase 4 | Status: RECRUITING